Facilitated Subcutaneous Immunoglobulin (fSCIG) Administration in
Secondary Immune Deficiency (SID) Due to Hematological Malignancies.
Efficacy and Safety Real-World Data from a Single-Center in Greece
Facilitated Subcutaneous Immunoglobulin (fSCIG) Administration in Secondary Immune Deficiency (SID) Due to Hematological Malignancies. Efficacy and Safety Real-World Data from a Single-Center in Greece
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2019
Συγγραφείς:
Dimou, Maria Pardalis, Vasileios Iliakis, Theodoros Bitsani, Aikaterini Grafakos, Ioannis Kalyva, Sotiria Markopoulos, Athanasios Kyrtsonis, Marie-Christine Panayiotidis, Panayiotis
